Dr Erin Karski | Associated Medical Director
Genentech | United States

Dr Erin Karski, Associated Medical Director, Genentech

Erin Karski is an associate medical director in cancer immunotherapy at Roche/Genentech.  She focuses on mainly on early phase immunotherapy combinations and the development of clinical trial platforms.  Dr. Karski completed her medical degree at the University of Minnesota and her pediatric hematology/oncology training at the University of California San Francisco.  After completing her training, she stayed on as junior faculty at UCSF where she focused on early phase trial development for pediatric solid tumors and the development of prognostic biomarkers in Ewing sarcoma.  She subsequently transitioned to Roche/Genentech where she has continued to focus on early phase clinical development.  She continues to see pediatric oncology patients at Lucile Packard Children’s Hospital Stanford. 

Appearances:



DC Co-conference Day 2 April 4 @ 12:40

Rapid and efficient development of combination therapies through a novel cancer immunotherapy platform.

  • Introduction to Morpheus; a novel cancer immunotherapy platform
  • How to go about selecting a combination study
  • Potential for use across several indications

back to speakers